Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.95%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.66Close
$ 2.45 - $ 65.4 52-Week Range
Ticker Information
Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQBIOAFFINITY TECHNOLOGIES INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BIAF - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 72.62K | 0.95% | $ 7.68M |
| 3/31/2025 | $ 84.41K | 0.96% | $ 8.81M |
| 12/31/2024 | $ 92.47K | 0.99% | $ 9.36M |
| 9/30/2024 | $ 92.75K | 0.99% | $ 9.37M |
| 6/30/2024 | $ 79.91K | 1.09% | $ 7.32M |
| 3/31/2024 | $ 59.02K | 1.2% | $ 4.94M |
| 12/31/2023 | $ 37.13K | 1.47% | $ 2.53M |
| 9/30/2023 | $ 69.84K | 21.73% | $ 321.49K |
| 6/30/2023 | $ 950.15K | 3933.56% | $ 24.16K |
| 3/31/2023 | $ 1.35M | 23555.06% | $ 5.72K |
Key Performance Insights, Last 5 Years
- BIOAFFINITY TECHNOLOGIES INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, BIOAFFINITY TECHNOLOGIES INC's average Int. Exp. % has been 7295.3%.
- The median Int. Exp. % for BIOAFFINITY TECHNOLOGIES INC during this period was 1.2%
- BIOAFFINITY TECHNOLOGIES INC reached its highest Int. Exp. % over the past 5 years at 52730.38%.
- The lowest Int. Exp. % recorded by BIOAFFINITY TECHNOLOGIES INC in the same timeframe 0.95%
BIOAFFINITY TECHNOLOGIES INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: Int. Exp. [ $ 1M ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] BIAF - Interest Expense Margin, Last 5 years
0.95%
Minimum
Jun 30, 2025
52730.38%
Maximum
Dec 31, 2022
7295.3%
Average
1.2%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |